Fig. 3From: Protective effect of Secukinumab on severe sepsis model rats by neutralizing IL-17A to inhibit IKBα/NFκB inflammatory signal pathwayContents of inflammatory factors TNF-α, IL-6, and IL-17A in plasma and lung tissue of rats in each group at 24 h. #P < 0.05 vs Sham, *P < 0.05 vs CLP, mean ± SD, one‐way ANOVA, double-tailed unpaired t test, n = 6/groupBack to article page